Empower Clinics to Open Chicago Medical Cannabis and Wellness Clinic
September 14th, 2018
News, Top News
New Illinois measure expands statewide access to medical cannabis as alternative to opioids
Empower Clinics Inc. (CSE: EPW; FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it has established a new clinic in downtown Chicago, as part of the company’s national expansion. This follows the late August signature of a statewide measure by Illinois’ governor to expand access to medical cannabis as an alternative for opioid painkillers.
This press release features multimedia. View the full release here:https://www.businesswire.com/news/home/20180912005374/en/
Located in downtown Chicago at 160 N. Upper Wacker Drive, the clinic is slated to open on September 24 and be staffed by licensed medical professionals and support personnel. Empower Clinics offers a variety of physician-guided treatments to address a multitude of chronic pain conditions, as well as anxiety, Post Traumatic Stress Disorder (PTSD) and chemotherapy side effects. The company’s branded line of CBD products will also be available through the clinic. Empower’s “Sollievo” (Italian for “relief”) products have been developed to specifically target the most common qualifying conditions, including pain, sleep disorders, stress, and digestive issues. The products, available as tinctures or topical creams, are non-THC CBD, meaning that they are non-psychotropic: they do not directly affect mood, perception, or consciousness.
ILLINOIS MEASURE OPENS ACCESS TO CANNABIS-BASED TREATMENT
The new Illinois measure, signed into law by Governor Bruce Rauner on August 28, enables doctors to prescribe medical cannabis to any patients who qualify for prescriptions to opioids such as Vicodin, OxyContin, or Percocet. According to the Chicago Tribune, the measure is a response to the epidemic of overdose deaths from narcotics, which killed nearly 2,000 people in Illinois in 2016 and 72,000 people nationwide.
Effective immediately, no qualifying applicants have to undergo fingerprinting or criminal background checks. Patients who complete an online application with a doctor’s authorization will receive provisional registration to purchase medical cannabis while they wait for state officials to conduct final reviews of their requests.
“Chicago is clearly one of the nation’s most vibrant metropolitan areas and we are thrilled to become part of this market, especially at such an important and progressive time in the state’s medical history,” said Craig Snyder, Empower CEO. “A broadening base of evidence shows that medical cannabis can be effective for treating pain and that it can reduce the parallel epidemics of opioid use and overdose deaths. We believe those who need treatment in Illinois and elsewhere deserve viable options that don’t involve opioids.”
According to Snyder, Empower plans to aggressively expand its national footprint to include clinics in multiple other states, complementing its clinic locations throughout Oregon and Washington, as well the new Chicago office. The company also intends to feature chiropractic, massage, nutrition, integrative medicine and other complimentary medical/wellness services at the new Chicago office, providing patients access to multiple healthcare offerings.
Empower is a leading owner and operator of medical cannabis and wellness clinics, as well as a developer of medical products in the US, focused on enabling individuals to improve and protect their health. The company provides treatment solutions through its physician-staffed clinics that are focused on education, data, and efficacy. Empower is a recognized leader and the first choice for patients seeking quality experience and improved health.
For further information about Empower please see the company’s website at empowerclinics.com or contact the following:
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. Forward-looking information contained in this news release includes, but is not limited to, the delisting of the Common Shares from the TSXV, the listing of the Common Shares on the CSE and the future growth plans of the Company. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events and are therefore based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.
Neither the TSXV, the CSE nor their Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: http://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.